The DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Modeling Alzheimer’s disease with iPSC-derived brain cells
Open accessAbstract
Alzheimer's disease is a devastating neurodegenerative disorder with no cure. Countless promising therapeutics have shown efficacy in rodent Alzheimer's disease models yet failed to benefit human patients. While hope remains that earlier intervention with existing therapeutics will improve outcomes, it is becoming increasingly clear that new approaches to understand and combat the pathophysiology of Alzheimer's disease are needed. Human induced pluripotent stem cell (iPSC) technologies have changed the face of preclinical research and iPSC-derived cell types are being utilized to study an array of human conditions, including neurodegenerative disease. All major brain cell types can now be differentiated from iPSCs, while increasingly complex co-culture systems are being developed to facilitate neuroscience research. Many cellular functions perturbed in Alzheimer's disease can be recapitulated using iPSC-derived cells in vitro, and co-culture platforms are beginning to yield insights into the complex interactions that occur between brain cell types during neurodegeneration. Further, iPSC-based systems and genome editing tools will be critical in understanding the roles of the numerous new genes and mutations found to modify Alzheimer's disease risk in the past decade. While still in their relative infancy, these developing iPSC-based technologies hold considerable promise to push forward efforts to combat Alzheimer's disease and other neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A majority of AD risk genes identified through genome-wide association studies are highly expressed in microglia, the brain’s innate immune cells, suggesting a key role in microglial dysfunction (Kummer et al., 2021; Penney et al., 2020; Teipel et al., 2022).”
From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Penney et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Population genetics has revealed that AD risk variants are enriched in genes that are highly expressed in microglia (Penney et al., 2020).”
From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Penney et al., 2020
In the citing paper
“While it is well documented that iPS cell systems can model aspects of AD pathology (Penney et al., 2020; Nelson et al., 2023)”
From APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases (2024) · cites this paper as Penney et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
Moreno, C. L., Guardia, L. D., Shnyder, V., Ortiz‐Virumbrales, M., Kruglikov, I., Zhang, B., Schadt, E. E., Tanzi, R. E., Noggle, S., Buettner, C., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0265-5 · Cited by 55
Chen, M., Lee, H. K., Moo, L. R., Hanlon, E. B., Stein, T. D., & Xia, W. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.04.032 · Cited by 53
Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
Robbins, J. P., Perfect, L., Ribé, E. M., Maresca, M., Dangla-Valls, A., Foster, E. M., Killick, R., Nowosiad, P., Reid, M. J., Polit, L. D., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00504 · Cited by 53
Mantle, J. L., & Lee, K. H. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.030 · Cited by 52
PPARβ/δ‐agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes
Konttinen, H., Gureviciene, I., Oksanen, M., Grubman, A., Loppi, S. H., Huuskonen, M. T., Korhonen, P., Lampinen, R., Keuters, M. H., Belaya, I., et al. (2018) · Glia · doi:10.1002/glia.23534 · Cited by 52
Wicklund, L., Leão, R. N., Strömberg, A., Mousavi, M. T., Hovatta, O., Nordberg, A. K., & Marutle, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015600 · Cited by 51
Wężyk, M., Szybińska, A., Wojsiat, J., Szczerba, M., Day, K., Rönnholm, H., Kele, M., Berdyński, M., Pepłońska, B., Fichna, J. P., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170830 · Cited by 51
Concise Review: Deciphering the Mechanism Behind Induced Pluripotent Stem Cell Generation
Lin, S.-L. (2011) · Stem Cells · doi:10.1002/stem.744 · Cited by 49
Roessler, R., Smallwood, S. A., Veenvliet, J. V., Pechlivanoglou, P., Peng, S.-P., Chakrabarty, K., Koerkamp, M. J. A. G., Pasterkamp, R. J., Wesseling, E. M., Kelsey, G., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.03.001 · Cited by 46
Miranda-Azpiazu, P., Panagiotou, S., Jose, G., & Saha, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-26480-8 · Cited by 44
Sullivan, S. E., Liao, M., Smith, R. V., White, C., Lagomarsino, V. N., Xu, J., Taga, M., Bennett, D. A., De Jager, P. L., & Young-Pearse, T. L. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy376 · Cited by 44
Begum, A. N., Guoynes, C. D., Cho, J., Hao, J., Lutfy, K., & Hong, Y. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.10.014 · Cited by 43
Wray, S., & Noble, W. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2234-09.2009 · Cited by 42
Modeling Alzheimer’s Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation
Chang, K., Lee‐Chen, G., Huang, C.-C., Lin, J.-L., Chen, Y.-J., Wei, P.-C., Lo, Y., Yao, C.-F., Kuo, M., & Chen, C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1336-x · Cited by 42
Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications
Chuah, J. K. C., & Zink, D. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.001 · Cited by 41
Zhang, M., Wang, L., An, K., Cai, J., Li, G., Yang, C., Liu, H., Du, F., Han, X., Zhang, Z., et al. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0313-0 · Cited by 39
Xu, M., Zhang, L., Liu, G., Jiang, N., Zhou, W., & Zhang, Y. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180722 · Cited by 39
Yuan, F., Chen, X., Fang, K.-H., Wang, Y., Lin, M., Xu, S., Huo, H.-Q., Xu, M., Ma, L., Chen, Y., et al. (2018) · eLife · doi:10.7554/elife.37382 · Cited by 36
Rebuzzini, P., Zuccotti, M., Redi, C. A., & Garagna, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2171-8 · Cited by 35
Dashinimaev, E. B., Artyuhov, A., Bolshakov, A. P., Vorotelyak, E. A., & Vasiliev, A. V. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160945 · Cited by 32
iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia
Li, L., Roh, J. H., Chang, E. H., Lee, Y. K., Lee, S., Kim, M., Koh, W., Chang, J. W., Kim, H. J., Nakanishi, M., et al. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.5.350 · Cited by 32
Sproul, A. A. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.06.007 · Cited by 31
Duan, L., Peng, C., Pan, L., & Kessler, J. A. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0137 · Cited by 27
Designing in vitro Blood-Brain Barrier Models Reproducing Alterations in Brain Aging
Osipova, E. D., Komleva, Y. K., Morgun, A. V., Lopatina, O. L., Panina, Y. A., Olovyannikova, R. Y., Vais, E. F., Salmin, V. V., & Salmina, A. B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00234 · Cited by 25
Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer’s Disease
Foveau, B., Correia, A. S., Hébert, S. S., Rainone, S., Potvin, O., Kergoat, M., Belleville, S., Duchesne, S., & LeBlanc, A. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180833 · Cited by 21
Berry, B. J., Smith, A. S. T., Long, C. J., Martin, C., & Hickman, J. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00067 · Cited by 19
Cota-Coronado, A., Ramírez-Rodríguez, P. B., Padilla‐Camberos, E., Díaz, É. F., Flores-Fernández, J. M., Ávila‐González, D., & Diaz-Martinez, N. E. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.10.001 · Cited by 19
Age-Related Epigenetic Derangement upon Reprogramming and Differentiation of Cells from the Elderly
Ravaioli, F., Bacalini, M. G., Franceschi, C., & Garagnani, P. (2018) · Genes · doi:10.3390/genes9010039 · Cited by 18
Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells
Pournasr, B., & Duncan, S. A. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309199 · Cited by 17
Visualizing Infralimbic Control over Incubation of Cocaine Craving
Jean-Richard-dit-Bressel, P., & McNally, G. P. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.008 · Cited by 15
Vazin, T., Ball, K. A., Lü, H., Park, H., Ataeijannati, Y., Head-Gordon, T. L., Poo, M., & Schaffer, D. V. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.12.012 · Cited by 12
Induced pluripotent stem cells and regenerative medicine
Chen, Y.-C., Tsai, K.-L., Hung, C.-W., Ding, D., Chen, L.-H., Chang, Y.-L., Chen, L., & Chiou, S. (2011) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2010.12.003 · Cited by 11
Canals, I., Ginisty, A., Quist, E., Timmerman, R., Fritze, J., Miskinyte, G., Monni, E., Hansen, M. G., Hidalgo, I., Bryder, D., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0264-z · Cited by 6
SP0136 Genomic Responses in Mouse Models Poorly Mimic Human Inflammatory Diseases
Tompkins, R. G. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-eular.1698 · Cited by 2
Flagged first, then by citations
1 of the 235 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 450
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
The complexity of Alzheimer’s disease: an evolving puzzle
Ferrari, C., & Sorbi, S. (2021) · Physiological Reviews · doi:10.1152/physrev.00015.2020 · Cited by 343
Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity
Victor, M. B., Leary, N., Luna, X., Meharena, H. S., Scannail, A. N., Bozzelli, P. L., Samaan, G., Murdock, M. H., von Maydell, D., Effenberger, A. H., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.07.005 · Cited by 316
Self-citationProteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
Bai, B., Vanderwall, D., Li, Y., Wang, X., Poudel, S., Wang, H., Dey, K. K., Chen, P., Yang, K., & Peng, J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00474-z · Cited by 267
Metadata
- Authors
- Penney, J., Ralvenius, W. T., & Tsai, L.-H.
- Affiliations
- Massachusetts Institute of Technology (US)
- Corresponding author
- Tsai, Li-Huei
- Venue
- Molecular Psychiatry
- Published
- 2019-08-07
- Volume
- 25
- Issue
- 1
- Pages
- 148-167
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC6906186
- OpenAlex
- W2964627277
- Cited by
- 471
- References
- 235
- Citations by year
- 2026: 54 · 2025: 66 · 2024: 78 · 2023: 84 · 2022: 77 · 2021: 65 · 2020: 41 · 2019: 6
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- IslandScholar (University of Prince Edward Island) (submittedVersion)
- Funders
- National Science Foundation
- Cure Alzheimer's Fund
- Robert A. and Renee E. Belfer Family Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (177920)
- National Institutes of Health (NS051874)
- National Institute on Aging (RF1AG054012)
- National Institute of Neurological Disorders and Stroke (R37NS051874)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- Alzheimer's disease, induced pluripotent stem cells, neurodegeneration, co-culture model, disease modeling, genome editing, Alzheimer's disease risk genes, preclinical research
- MeSH terms
- Alzheimer Disease, Brain, Cell Differentiation, Humans, Models, Biological, Neurons, Neurodegenerative Diseases, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
